ALSO IN THIS MONTH'S ISSUE
Skills I Learned That Have Helped Me As A Public Pharma CEO
While I learned a great deal about the industry in the latter part of my career, as a leader, my foundation was molded by the valuable lessons learned in two very different spaces — the U.S. Army Reserve and nursing.
How Quality Management Science Can Build A 5-Star Company
The following four concepts based on the science of quality management may serve to shift your mindset while you are considering how to define the company or organization that you, as the leader, deem five-star worthy.
Companies To Watch: Atea Pharmaceuticals
Atea Pharmaceuticals is creating new nucleotide antivirals, including one the company is jointly developing with Roche to fight COVID-19.
Going Precommercial — From The Commercial World
Nancy Lurker, a veteran Big-Pharma marketer, now runs a small biopharma. And she admits, “the business models are very, very different.”
BEYOND THE PRINTED PAGE
CEO Advice From A 30-Year Pharma Veteran10/18/2021
Lisa Conte, founder of Jaguar Health, shares her thoughts on becoming a biopharmaceutical company CEO, and the approach taken to create the proper corporate culture.
Don’t Think Executing A Biopharma SPAC Is Easy9/20/2021
Michael Byrnes, CFO at eFFECTOR Therapeutics, provides a prequel to an upcoming two-part article in Life Science Leader, with some specific recommendations for executive teams on SPACs.
John C. Martin, A Much-Missed Mentor And Kronos Bio Board Member8/23/2021
Nobert Bischofberger, Ph.D., CEO of Kronos Bio, reflects on lessons learned from an important mentor and biotech icon.